Patients with Hashimoto's thyroiditis who are considering GLP-1 medications should have a thorough discussion with their GP or endocrinologist
Metoprolol, a selective beta-1 blocker, reduces heart rate and blood pressure by blocking adrenaline effects on the heart
Weight Loss Up to ~21% reduction Sustained at 72 weeks Beats GLP-1 alone Glycemic Control Lower HbA1c Steadier blood sugar GIP boosts response Cardiometabolic Lower blood pressure Better lipid panel Trial signals on CV Appetite Control Quieter cravings Smaller portions Less food noise Lose more weight on your terms
Unlike other cognitive enhancers, our Jupiter Dihexa peptide therapy specifically targets the brains regenerative processes, making it a powerful tool for boosting memory, focus, and overall cognitive performance
In the FLOW trial, semaglutide slowed eGFR decline and reduced the incidence of renal events, including progression to kidney failure, in people with diabetic CKD [199]